StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)

Close on Nov 17, 2026Market cap $46.93MP/E –Yield –

RenovoRx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for RenovoRx

RenovoRx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More RenovoRx figures

See a number that looks wrong?